Heinz Wiendl just had the pleasure of presenting at the European Academy of Neurology (EAN) in Helsinki the five hottest developments in neuroimmunology: clinical sciences.
This format is a contribution of ISNI (International Society of Neuroimmunology) in teaming up with EAN (session was done together with Roberta Maggliozi presenting the Basic Science part)
What did he present and consider top on his personal list?
1) Development of New Diagnostic Criteria for MS
2) Bruton Tyrosine Kinase Inhibitors (BTKi) for MS Treatment
3) Early MS consists of 3 Immunological Endophenotypes with different disease trajectories and responses to immune therapies
4) Myasthenia Gravis is the New MS! (with regard to its dynamic, success in identifying novel treatment targets)
Massive evolution of treatment options, particularly
I) the class of FcRn modulators
II) the class of complement inhibitors
but also novel treatment goals (complete remission of the disease!)
5) NMOSD and MOGAD: Precision Medicine Breakthroughs
#Neuroimmunology #MSResearch #MyastheniaGravis #NMOSD #MOGAD #PrecisionMedicine #Neurology #MedicalResearch #EAN2024 #ISNI
C.F. 97644730588 | Managed by EEM Services